|
Jul 24
|
New Strong Sell Stocks for July 24th
|
|
Jul 23
|
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 22
|
Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
|
|
Jul 21
|
Ophthalmic Implants Market: Focused Insights (2025-2030) Featuring Alcon, Carl Zeiss, Bausch + Lomb, Johnson & Johnson and 20 Other Industry Leaders
|
|
Jul 21
|
Medical Devices & Supplies - Specialty Stocks Q1 In Review: Bausch + Lomb (NYSE:BLCO) Vs Peers
|
|
Jul 15
|
Bausch + Lomb Maintained at Outperform at RBC Ahead of Q2 Results; Price Target Kept at US$17.00
|
|
Jul 15
|
Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says
|
|
Jul 15
|
Bausch + Lomb Q2 Earnings to Benefit From FX Tailwinds, Eye Drop Sales, RBC Says
|
|
Jul 1
|
Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye
|
|
Jun 30
|
Insider Stock Buying Reaches US$1.54m On Bausch + Lomb
|
|
Jun 30
|
Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13
|
|
Jun 26
|
Bausch + Lomb Closes Senior Secured Notes Offering, Refinancing And Upsizes US$2.32 Billion Term Loan Facility
|
|
Jun 26
|
Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility
|
|
Jun 25
|
The Top 5 Analyst Questions From Bausch + Lomb’s Q1 Earnings Call
|
|
Jun 18
|
Bausch + Lomb Prices Upsizes and Prices a 675-Million Euro Senior Secured Notes Offering
|
|
Jun 18
|
Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering
|
|
Jun 10
|
Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement
|
|
May 7
|
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
|
|
Feb 14
|
Stocks to watch this week: Alibaba, Walmart, HSBC, Rio Tinto and Lloyds
|
|
Jan 3
|
Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI
|